Semaglutide

A GLP‑1 receptor agonist with proven ASCVD benefit and strong weight loss is a great candidate drug for patients with cardiovascular disease and obesity. However, it is preferred for HFpEF and it has not been shown to reduce HFrEF hospitalization. It may be added later for weight or ASCVD risk, but it does not replace another cardioprotective drug for HF benefit as a first step.

  • Further Developments
End Session and View Feedback
  • How many leisure time cards could you choose? [undo]
  • MSA [undo]
  • Prefiere sentarse solo. [undo]
  • ΚΛΙΝΙΚΗ ΕΞΕΤΑΣΗ [undo]
  • Descripción de las células 1 [undo]
  • Παραμονή του stent και παρακολούθηση [undo]
  • Start B12 administration [undo]
  • Θα παραπέμψεις τον ασθενή να υποβληθεί σε βρογχοσκόπηση [undo]
  • Privacy risk [undo]
  • Exenatide [undo]
  • Ρήξη ουρητήρα [undo]
  • Explain the procedure [undo]
  • Συμπέρασμα [undo]
  • Metformin [undo]
  • ΑΠΟΤΕΛΕΣΜΑΤΑ ΒΙΟΧΗΜΙΚΩΝ ΕΞΕΤΑΣΕΩΝ [undo]
  • Opțiunea 2: Pentru a identifica și manipula corespunzător materialele periculoase din laborator [undo]
  • Θα τον στείλεις σε θωρακοχειρουργό [undo]
  • Insulin detemir [undo]
  • Option 2 [undo]
  • Carros? [undo]
  • Πολυμεράση Taq [undo]
  • Vârful rădăcinii de ceapă [undo]
  • Examination [undo]
  • ΑΙΜΟΡΡΑΓΙΑ ΑΠΟ ΓΕΣ [undo]
  • Game Over [undo]
  • Πρωτεϊνοσύνθεση [undo]
  • Game Over [undo]
  • Quit therapy for now [undo]
  • Ωτοσκόπηση [undo]
  • Explain the procedure and ask for his consensus [undo]
  • Node 3: Address each concern in detail [undo]
  • Gastrointestinal symptoms [undo]
  • Osmosis [undo]
  • Ζητώ καρυότυπο [undo]
  • Respuesta 2 [undo]
  • Amlodipine (Calcium Channel Blocker) Adverse Effects [undo]
  • Genome Sequencing [undo]
  • Tell the patient to change devices without giving proper guidance. [undo]
  • Sitagliptin [undo]
  • Mental Status [undo]
  • Cranial Nerves [undo]
  • Stop the compressions and move the victim into a stable lateral position. [undo]
  • Aumentando la temperatura y el pH [undo]
  • [undo]
  • Semaglutide [undo]

Map: Michael Green_GEMD_1 (1115)
Node: 21100
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway

  • Cut down on sugar intake
  • How many leisure time cards could you choose?
  • MSA
  • Prefiere sentarse solo.
  • ΚΛΙΝΙΚΗ ΕΞΕΤΑΣΗ
  • Descripción de las células 1
  • Παραμονή του stent και παρακολούθηση
  • Start B12 administration
  • Θα παραπέμψεις τον ασθενή να υποβληθεί σε βρογχοσκόπηση
  • Privacy risk
  • Exenatide
  • Ρήξη ουρητήρα
  • Explain the procedure
  • Συμπέρασμα
  • Metformin
  • ΑΠΟΤΕΛΕΣΜΑΤΑ ΒΙΟΧΗΜΙΚΩΝ ΕΞΕΤΑΣΕΩΝ
  • Opțiunea 2: Pentru a identifica și manipula corespunzător materialele periculoase din laborator
  • Θα τον στείλεις σε θωρακοχειρουργό
  • Insulin detemir
  • Option 2
  • Carros?
  • Πολυμεράση Taq
  • Vârful rădăcinii de ceapă
  • Examination
  • ΑΙΜΟΡΡΑΓΙΑ ΑΠΟ ΓΕΣ
  • Game Over
  • Πρωτεϊνοσύνθεση
  • Game Over
  • Quit therapy for now
  • Ωτοσκόπηση
  • Explain the procedure and ask for his consensus
  • Node 3: Address each concern in detail
  • Gastrointestinal symptoms
  • Osmosis
  • Ζητώ καρυότυπο
  • Respuesta 2
  • Amlodipine (Calcium Channel Blocker) Adverse Effects
  • Genome Sequencing
  • Tell the patient to change devices without giving proper guidance.
  • Sitagliptin
  • Mental Status
  • Cranial Nerves
  • Stop the compressions and move the victim into a stable lateral position.
  • Aumentando la temperatura y el pH
  • Semaglutide

Reminder

empty_reminder_msg

FINISH

Time is up